In summary, this study has demonstrated that lung tissue mast cell populations in COPD and IPF-affected lungs have spatially complex and markedly upregulated CPA3 expression profiles that correlate with sites of structural pathologies. This evidence concerns the gene CPA3 and chronic obstructive pulmonary disease.